Meyohas M C, Roux P, Bollens D, Chouaid C, Rozenbaum W, Meynard J L, Poirot J L, Frottier J, Mayaud C
Service des Maladies Infectieuses et Tropicales, Hôpital Saint-Antoine, Paris, France.
Clin Infect Dis. 1995 Sep;21(3):628-33. doi: 10.1093/clinids/21.3.628.
We reviewed the records of 85 patients infected with both human immunodeficiency virus and Cryptococcus neoformans. Twenty-seven patients (32%) had pulmonary cryptococcosis. C. neoformans was cultured from bronchoalveolar lavage (BAL) or pleural fluid in 25 cases; the remaining two patients had cryptococcal antigen (CA) detected in BAL fluid and C. neoformans cultured from other sites. All but one of the 27 patients had detectable CA in serum. The CD4+ lymphocyte count was low in all cases (median, 24/mm3). Clinical manifestations of pulmonary cryptococcosis included fever (94%), cough (71%), dyspnea (7%), expectoration (4%), chest pain (2%), and hemoptysis (1%). Diffuse interstitial opacities (70.5%), focal interstitial abnormalities, alveolar opacities, adenopathies, cavitary lesions, and pleural effusions were evident. Outcome was poor (mean survival time, 23 weeks) despite treatment. Patients with localized pulmonary cryptococcosis appeared to have a higher CD4+ lymphocyte count, an earlier diagnosis, lower serum CA titers, fewer previous or concomitant infections, and a better prognosis than patients with disseminated cryptococcosis.
我们回顾了85例同时感染人类免疫缺陷病毒和新型隐球菌的患者记录。27例患者(32%)患有肺隐球菌病。25例患者的支气管肺泡灌洗(BAL)液或胸腔积液中培养出新型隐球菌;其余2例患者的BAL液中检测到隐球菌抗原(CA),且在其他部位培养出新型隐球菌。27例患者中除1例之外,其余患者血清中均可检测到CA。所有病例的CD4+淋巴细胞计数均较低(中位数为24/mm³)。肺隐球菌病的临床表现包括发热(94%)、咳嗽(71%)、呼吸困难(7%)、咳痰(4%)、胸痛(2%)和咯血(1%)。可见弥漫性间质混浊(70.5%)、局灶性间质异常、肺泡混浊、淋巴结病、空洞性病变和胸腔积液。尽管进行了治疗,但预后较差(平均生存时间为23周)。与播散性隐球菌病患者相比,局限性肺隐球菌病患者的CD4+淋巴细胞计数似乎更高、诊断更早、血清CA滴度更低、既往或合并感染更少,且预后更好。